Harmony Biosciences

Harmony Biosciences is a commercial-stage pharmaceutical company that develops and commercializes therapies for rare neurological diseases, including sleep-wake disorders and epilepsy. Its lead product is WAKIX (pitolisant), approved for excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company's stated mission is to bring innovative therapies to patients with unmet needs.